Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Drug Majors Agree on Price Cuts for AIDS Drugs in Burkina Faso

May 10, 2001

Burkina Faso's Health Minister Pierre Tapsoba said on Wednesday that an agreement had been reached between Bristol Myers Squibb, GlaxoSmithkline and Merck Sharp and Dome to lower the price of antiretroviral drugs by up to 96 percent. Tapsoba stressed that despite the drop in price, the average person in the country would still not be able to afford the drugs. Burkina Faso follows the Ivory Coast as the West African country most affected by HIV/AIDS with 7.7 percent of the population HIV-positive.


Back to other CDC news for May 10, 2001

Previous Updates

Adapted from:
Agence France Presse
05.10.01


  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More on HIV/AIDS Treatment in Burkina Faso

Tools
 

Advertisement